Renji Reghunathan
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 1
-
- Mast cells and histamine 1
-
- Multiple Myeloma Research and Treatments 1
-
- Cancer therapeutics and mechanisms 1
- Ubiquitin and proteasome pathways 1
- Receptor Mechanisms and Signaling 1
-
- Respiratory viral infections research 1
-
- Viral-associated cancers and disorders 1
- Co-authors
- J. ManikandanAlirio J. MelendezLi Yang HsuBernard P. LeungDessmon Y.H. TaiHwee Kee TayMary RauffZhi Liang
- Partner nations
- SingaporeSouth KoreaUnited Kingdom
In The Last Decade
Renji Reghunathan
5 papers receiving 371 citations
Peers
Comparison fields: 5 of 69
- Infectious Diseases 141
- Immunology 159
- Immunology and Allergy 23
- Animal Science and Zoology 31
- Hematology 32
Countries citing papers authored by Renji Reghunathan
This map shows the geographic impact of Renji Reghunathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renji Reghunathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renji Reghunathan more than expected).
Fields of papers citing papers by Renji Reghunathan
This network shows the impact of papers produced by Renji Reghunathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renji Reghunathan. The network helps show where Renji Reghunathan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Renji Reghunathan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 8 | |
| 2 | 2013 | 31 | |
| 3 | 2009 | 49 | |
| 4 | 2006 | 60 | |
| 5 | 2005 | 230 |
About Renji Reghunathan
Renji Reghunathan is a scholar working on Immunology, Animal Science and Zoology, Hematology, Rheumatology and Pathology and Forensic Medicine, having authored 5 papers that have together received 378 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (1 paper), Mast cells and histamine (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Respiratory viral infections research (1 paper), Viral-associated cancers and disorders (1 paper), Ubiquitin and proteasome pathways (1 paper), Multiple Myeloma Research and Treatments (1 paper) and Receptor Mechanisms and Signaling (1 paper). The work is most often cited by research in Infectious Diseases (141 citations), Immunology (159 citations), Immunology and Allergy (23 citations), Animal Science and Zoology (31 citations) and Hematology (32 citations). Renji Reghunathan has collaborated with scholars based in Singapore, South Korea and United Kingdom. Frequent co-authors include J. Manikandan, Alirio J. Melendez, Li Yang Hsu, Bernard P. Leung, Dessmon Y.H. Tai, Hwee Kee Tay, Mary Rauff, Zhi Liang, Wee Joo Chng and Gaofeng Huang. Their work appears in journals such as Blood, BMC Genomics, Oncotarget, BMC Immunology and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.